Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Cancers
|
September 28, 2021
Tumor-Associated Macrophages in Bladder Cancer: Biological Role, Impact on Therapeutic Response and Perspectives for Immunotherapy
Marine M Leblond, Hana Zdimerova, Emma Desponds, et al.
Veterinary Pathology
|
September 9, 2020
Human CD34<sup>+</sup> Hematopoietic Stem Cell-Engrafted NSG Mice: Morphological and Immunophenotypic Features
Sandra Blümich, Hana Zdimerova, Christian Münz, et al.
Cancers
|
June 27, 2024
Development of Traceable Mouse Models of Advanced and Metastatic Bladder Cancer
Emma Desponds, Konstantina Kioseoglou, Hana Zdimerova, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
April 9, 2019
Infection and immune control of human oncogenic γ-herpesviruses in humanized mice
Donal McHugh, Nicole Caduff, Anita Murer, et al.
European Journal of Immunology
|
April 29, 2023
MHC class II-deficient mice allow functional human CD4<sup>+</sup> T-cell development
Fabienne Läderach, Hana Zdimerova, Lisa Rieble, et al.
Cell Death & Disease
|
October 21, 2022
Epstein Barr virus-mediated transformation of B cells from XIAP-deficient patients leads to increased expression of the tumor suppressor CADM1
Christine Engelmann, Patrick Schuhmachers, Hana Zdimerova, et al.
Cancers
|
January 26, 2024
Immuno-Transcriptomic Profiling of Blood and Tumor Tissue Identifies Gene Signatures Associated with Immunotherapy Response in Metastatic Bladder Cancer
Emma Desponds, Davide Croci, Victoria Wosika, et al.
Blood
|
April 7, 2021
CD27 is required for protective lytic EBV antigen-specific CD8+ T-cell expansion
Yun Deng, Bithi Chatterjee, Kyra Zens, et al.
European Journal of Immunology
|
September 19, 2020
Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15
Hana Zdimerova, Anita Murer, Christine Engelmann, et al.
Plos Pathogens
|
May 31, 2019
CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo
Bithi Chatterjee, Yun Deng, Angelika Holler, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Cancers
|
September 28, 2021
Tumor-Associated Macrophages in Bladder Cancer: Biological Role, Impact on Therapeutic Response and Perspectives for Immunotherapy
Marine M Leblond, Hana Zdimerova, Emma Desponds, et al.
Veterinary Pathology
|
September 9, 2020
Human CD34<sup>+</sup> Hematopoietic Stem Cell-Engrafted NSG Mice: Morphological and Immunophenotypic Features
Sandra Blümich, Hana Zdimerova, Christian Münz, et al.
Cancers
|
June 27, 2024
Development of Traceable Mouse Models of Advanced and Metastatic Bladder Cancer
Emma Desponds, Konstantina Kioseoglou, Hana Zdimerova, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
April 9, 2019
Infection and immune control of human oncogenic γ-herpesviruses in humanized mice
Donal McHugh, Nicole Caduff, Anita Murer, et al.
European Journal of Immunology
|
April 29, 2023
MHC class II-deficient mice allow functional human CD4<sup>+</sup> T-cell development
Fabienne Läderach, Hana Zdimerova, Lisa Rieble, et al.
Cell Death & Disease
|
October 21, 2022
Epstein Barr virus-mediated transformation of B cells from XIAP-deficient patients leads to increased expression of the tumor suppressor CADM1
Christine Engelmann, Patrick Schuhmachers, Hana Zdimerova, et al.
Cancers
|
January 26, 2024
Immuno-Transcriptomic Profiling of Blood and Tumor Tissue Identifies Gene Signatures Associated with Immunotherapy Response in Metastatic Bladder Cancer
Emma Desponds, Davide Croci, Victoria Wosika, et al.
Blood
|
April 7, 2021
CD27 is required for protective lytic EBV antigen-specific CD8+ T-cell expansion
Yun Deng, Bithi Chatterjee, Kyra Zens, et al.
European Journal of Immunology
|
September 19, 2020
Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15
Hana Zdimerova, Anita Murer, Christine Engelmann, et al.
Plos Pathogens
|
May 31, 2019
CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo
Bithi Chatterjee, Yun Deng, Angelika Holler, et al.
Page
of 1